In the present study, we screened primary neuroblastomas by next generation sequencing and our results reveal that TIAM1 variants in the domains signaling to MYC, RAS and RAC significantly predict better prognosis in neuroblastoma patients. The gene discussed is AKT1; the disease is neuroblastoma.